Patrick Mooney

Articles by Patrick Mooney

Digging into the 6-month first-in-human clinical trial data from SpyGlass Pharma

ByPatrick Mooney,Emily Kaiser Maharjan, Assistant Managing Editor

February 14th 2023

Patrick Mooney, CEO of SpyGlass Pharma, sits down to discuss the 6-month first-in-human clinical trial data of their drug delivery platform with bimatoprost, which is implanted during routine cataract surgery.

Latest Updated Articles

Patrick Mooney

Articles by Patrick Mooney

Digging into the 6-month first-in-human clinical trial data from SpyGlass Pharma

Latest Updated Articles

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

The A to Zzzs of ocular health

Crafting your own eyewear brand: Secrets to success

New study finds collarettes more common in patients with moderate-to-severe DED

The microbiome in diabetes and DR

Treatment Selection in Dry Eye Disease